Bengaluru: Biocon executive chairperson Kiran Mazumdar Shaw has tested positive for COVID-19.
Shaw informed this in a tweet on Monday night.
Biocon was recently in the news for making the controversial drug Itolizumab.
In July, Shaw claimed that Itolizumab had been approved in India and since the country was in a medical emergency, it was decided to go ahead with a clinical trial involving a cohort of 30 patients.’
She had further said the regulatory process was extremely robust and the scientific discussions on the trial were of a very high order.
New Delhi: A private plane crashed in Gramado, a popular mountain resort town in Brazil,…
Keonjhar: Desecration of a Hanuman idol in Barbil area of Odisha's Keonjhar district triggered stiff…
Mumbai: The much-delayed schedule for the 2025 Champions Trophy has been finalised. As per the…
Raipur: Did actor Sunny Leone enroll for a Chhattisgarh government’s beneficiary scheme for economically weaker…
Berhampur: Continuing to target places of worship in different parts of Odisha, burglars struck at…
New York: US President-elect Donald Trump has nominated an Indian American entrepreneur and former aide…
This website uses cookies.